Online Program Home
My Program

CC = Colorado Convention Center   H = Hyatt Regency Denver at Colorado Convention Center
* = applied session       ! = JSM meeting theme

Activity Details

467 Wed, 7/31/2019, 8:30 AM - 10:20 AM CC-113
Modeling, Design Strategies and Assessment of Biomarkers — Contributed Papers
Biopharmaceutical Section
Chair(s): Yodit Seifu, Merck
8:35 AM Modeling the Prediction Classifier of Overall Survival with Clinical and Gene Expression Data of Leukemia Patients – a Case Study

Kao-Tai Tsai, Celgene
8:50 AM A New Method for the Analysis of Categorical Data with Repeated Measurements - Demonstrated by Precision Data Analysis for Clinical Diagnostics

Tinghui Yu, AstraZeneca
9:05 AM Learning Moral Graphs in Construction of High-Dimensional Bayesian Networks for Mixed Data

Bochao Jia, Eli Lilly and Company; Suwa Xu, University of Florida; Faming Liang, Purdue University
9:20 AM Biomarker Enrichment Subgroup Analysis - a Case Study
Rui Qin, Johnson & Johnson; Steven Sun, J&J; Grace Liu, Johnson & Johnson
9:35 AM Design Strategies to Assess Benefit for Biomarker Sub-Populations in Phase III Clinical Trials

Bharani Dharan, Novartis Pharmaceuticals; Ekkehard Glimm, Novartis Pharma AG
9:50 AM Exact Bayesian Screening for Rapidly Identifying Uninformative Features from High-Dimensional Biomedical Arrays

A Lawrence Gould, Merck Research Laboratories; Richard Baumgartner, Merck Research Laboratories
10:05 AM Prognostic Models from Data Integration of Clinical Characteristics and Gene Expression Data Using Bayesian Networks
Duncan Rotich, University of Kansas Medical Center; Jeffrey A. Thompson, University of Kansas Medical Center